METTL3 and neoplasm: On the immunologic side, lactate-driven METTL3 in myeloid cells fosters suppression, whereas myeloid METTL3 has also been reported to support anti-tumor responses under different cues, echoing a broader pattern in which cell type, metabolic state, and inflammatory tone determine whether m6A skews toward immune evasion or activation.